SCHEMBL6662871

SCHEMBL6662871

CCOC(=O)c1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 18/20 0.77
KDM4E B2RXH2 1/20 0.72
ALDH1A1 P00352 1/20 0.72
HPGD P15428 1/20 0.72
EGFR P00533 11/20 0.69
RAB9A P51151 1/20 0.67
GAK O14976 1/20 0.65
RIPK2 O43353 1/20 0.65
STK10 O94804 1/20 0.65
RET P07949 1/20 0.65
FLT3 P36888 1/20 0.65
JAK3 P52333 1/20 0.65
AAK1 Q2M2I8 1/20 0.65
Q6ZSR9 Q6ZSR9 1/20 0.65
SLK Q9H2G2 1/20 0.65
IRAK4 Q9NWZ3 1/20 0.65
RPS6KA6 Q9UK32 1/20 0.65
ALK Q9UM73 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5473733 0.85 KDR (0.74) KDREGFRGAKRIPK2STK10
SCHEMBL28726464 0.84 KDR (0.76) KDREGFRGAKRIPK2STK10
SCHEMBL5569469 0.84 KDR (0.72) KDREGFRGAKRIPK2STK10
Hydrochloric Acid SCHEMBL5477767 0.84 EGFR (0.73) KDREGFRGAKRIPK2STK10
SCHEMBL25682990 0.82 KDR (0.78) KDREGFRGAKRIPK2STK10
SCHEMBL6162829 0.82 KDR (0.70) KDREGFR
SCHEMBL6162952 0.82 KDR (0.70) KDREGFR
SCHEMBL18158156 0.82 AURKB (0.80) KDREGFRGAKRIPK2STK10
Hydrochloric Acid SCHEMBL8809205 0.81 AURKB (0.78) KDREGFRGAKRIPK2STK10
SCHEMBL5473778 0.81 EGFR (0.80) KDREGFRGAKRIPK2STK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO claimed
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO disclosed